4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-008519
Options or other derivatives
- President & CEO acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PIMSTONE SIMON N. · President & CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-03-11 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +50,000 | $7.49 | 2026-03-10 | 50,000 | 50,000 | D |
Loading xslF345X03/formfour.xml…